Maryam Khalid

Maryam Khalid, Fadeel Sher Khan, John Broussard et al.

Early diagnosis and discovery of therapeutic drug targets are crucial objectives for the effective management of Alzheimer's Disease (AD). Current approaches for AD diagnosis and treatment planning are based on radiological imaging and largely inaccessible for population-level screening due to prohibitive costs and limited availability. Recently, blood tests have shown promise in diagnosing AD and highlighting possible biomarkers that can be used as drug targets for AD management. Blood tests are significantly more accessible to disadvantaged populations, cost-effective, and minimally invasive. However, biomarker discovery in the context of AD diagnosis is complex as there exist important associations between various biomarkers. Here, we introduce BRAIN (Biomarker Representation, Analysis, and Interpretation Network), a novel machine learning (ML) framework to jointly optimize the diagnostic accuracy and biomarker discovery processes to identify all relevant biomarkers that contribute to AD diagnosis. Using a holistic graph-based representation for biomarkers, we highlight their inter-dependencies and explain why different ML models identify different discriminative biomarkers. We apply BRAIN to a publicly available blood biomarker dataset, revealing three novel biomarker sub-networks whose interactions vary between the control and AD groups, offering a new paradigm for drug discovery and biomarker analysis for AD.

Maryam Khalid, Elizabeth B. Klerman, Andrew W. Mchill et al.

Sleep behavior significantly impacts health and acts as an indicator of physical and mental well-being. Monitoring and predicting sleep behavior with ubiquitous sensors may therefore assist in both sleep management and tracking of related health conditions. While sleep behavior depends on, and is reflected in the physiology of a person, it is also impacted by external factors such as digital media usage, social network contagion, and the surrounding weather. In this work, we propose SleepNet, a system that exploits social contagion in sleep behavior through graph networks and integrates it with physiological and phone data extracted from ubiquitous mobile and wearable devices for predicting next-day sleep labels about sleep duration. Our architecture overcomes the limitations of large-scale graphs containing connections irrelevant to sleep behavior by devising an attention mechanism. The extensive experimental evaluation highlights the improvement provided by incorporating social networks in the model. Additionally, we conduct robustness analysis to demonstrate the system's performance in real-life conditions. The outcomes affirm the stability of SleepNet against perturbations in input data. Further analyses emphasize the significance of network topology in prediction performance revealing that users with higher eigenvalue centrality are more vulnerable to data perturbations.